BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 29105665)

  • 1. S-Ketamine-Induced NMDA Receptor Blockade during Natural Speech Production and Its Implications for Formal Thought Disorder in Schizophrenia: A Pharmaco-fMRI Study.
    Nagels A; Cabanis M; Oppel A; Kirner-Veselinovic A; Schales C; Kircher T
    Neuropsychopharmacology; 2018 May; 43(6):1324-1333. PubMed ID: 29105665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of ketamine on brain function during smooth pursuit eye movements.
    Steffens M; Becker B; Neumann C; Kasparbauer AM; Meyhöfer I; Weber B; Mehta MA; Hurlemann R; Ettinger U
    Hum Brain Mapp; 2016 Nov; 37(11):4047-4060. PubMed ID: 27342447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glutamate and the neural basis of the subjective effects of ketamine: a pharmaco-magnetic resonance imaging study.
    Deakin JF; Lees J; McKie S; Hallak JE; Williams SR; Dursun SM
    Arch Gen Psychiatry; 2008 Feb; 65(2):154-64. PubMed ID: 18250253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuronal correlates of visual and auditory alertness in the DMT and ketamine model of psychosis.
    Daumann J; Wagner D; Heekeren K; Neukirch A; Thiel CM; Gouzoulis-Mayfrank E
    J Psychopharmacol; 2010 Oct; 24(10):1515-24. PubMed ID: 19304859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does ketamine mimic aspects of schizophrenic speech?
    Covington MA; Riedel WJ; Brown C; He C; Morris E; Weinstein S; Semple J; Brown J
    J Psychopharmacol; 2007 May; 21(3):338-46. PubMed ID: 17591660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychological effects of (S)-ketamine and N,N-dimethyltryptamine (DMT): a double-blind, cross-over study in healthy volunteers.
    Gouzoulis-Mayfrank E; Heekeren K; Neukirch A; Stoll M; Stock C; Obradovic M; Kovar KA
    Pharmacopsychiatry; 2005 Nov; 38(6):301-11. PubMed ID: 16342002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neural correlates of S-ketamine induced psychosis during overt continuous verbal fluency.
    Nagels A; Kirner-Veselinovic A; Krach S; Kircher T
    Neuroimage; 2011 Jan; 54(2):1307-14. PubMed ID: 20727411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mismatch negativity generation in the human 5HT2A agonist and NMDA antagonist model of psychosis.
    Heekeren K; Daumann J; Neukirch A; Stock C; Kawohl W; Norra C; Waberski TD; Gouzoulis-Mayfrank E
    Psychopharmacology (Berl); 2008 Jul; 199(1):77-88. PubMed ID: 18488201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ketamine effects on brain function--simultaneous fMRI/EEG during a visual oddball task.
    Musso F; Brinkmeyer J; Ecker D; London MK; Thieme G; Warbrick T; Wittsack HJ; Saleh A; Greb W; de Boer P; Winterer G
    Neuroimage; 2011 Sep; 58(2):508-25. PubMed ID: 21723949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversed lateralization of temporal activation during speech production in thought disordered patients with schizophrenia.
    Kircher TT; Liddle PF; Brammer MJ; Williams SC; Murray RM; McGuire PK
    Psychol Med; 2002 Apr; 32(3):439-49. PubMed ID: 11989989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of ketamine on configural facial processing.
    MBSc EN; Joshua N; Morgan C; Rossell SL
    J Clin Psychopharmacol; 2015 Apr; 35(2):188-91. PubMed ID: 25679135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ketamine-Induced Modulation of the Thalamo-Cortical Network in Healthy Volunteers As a Model for Schizophrenia.
    Höflich A; Hahn A; Küblböck M; Kranz GS; Vanicek T; Windischberger C; Saria A; Kasper S; Winkler D; Lanzenberger R
    Int J Neuropsychopharmacol; 2015 Apr; 18(9):. PubMed ID: 25896256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ketamine and fMRI BOLD signal: distinguishing between effects mediated by change in blood flow versus change in cognitive state.
    Abel KM; Allin MP; Kucharska-Pietura K; Andrew C; Williams S; David AS; Phillips ML
    Hum Brain Mapp; 2003 Feb; 18(2):135-45. PubMed ID: 12518293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses.
    Krystal JH; Karper LP; Seibyl JP; Freeman GK; Delaney R; Bremner JD; Heninger GR; Bowers MB; Charney DS
    Arch Gen Psychiatry; 1994 Mar; 51(3):199-214. PubMed ID: 8122957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological modulation of the neural basis underlying inhibition of return (IOR) in the human 5-HT2A agonist and NMDA antagonist model of psychosis.
    Daumann J; Heekeren K; Neukirch A; Thiel CM; Möller-Hartmann W; Gouzoulis-Mayfrank E
    Psychopharmacology (Berl); 2008 Nov; 200(4):573-83. PubMed ID: 18649072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ketamine induces a robust whole-brain connectivity pattern that can be differentially modulated by drugs of different mechanism and clinical profile.
    Joules R; Doyle OM; Schwarz AJ; O'Daly OG; Brammer M; Williams SC; Mehta MA
    Psychopharmacology (Berl); 2015 Nov; 232(21-22):4205-18. PubMed ID: 25980482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of ketamine on prefrontal and striatal regions in an overt verbal fluency task: a functional magnetic resonance imaging study.
    Fu CH; Abel KM; Allin MP; Gasston D; Costafreda SG; Suckling J; Williams SC; McGuire PK
    Psychopharmacology (Berl); 2005 Nov; 183(1):92-102. PubMed ID: 16228196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of ketamine-induced psychopathological symptoms on continuous overt rhyme fluency.
    Nagels A; Kirner-Veselinovic A; Wiese R; Paulus FM; Kircher T; Krach S
    Eur Arch Psychiatry Clin Neurosci; 2012 Aug; 262(5):403-14. PubMed ID: 22189657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NMDA hypofunction in the posterior cingulate as a model for schizophrenia: an exploratory ketamine administration study in fMRI.
    Northoff G; Richter A; Bermpohl F; Grimm S; Martin E; Marcar VL; Wahl C; Hell D; Boeker H
    Schizophr Res; 2005 Jan; 72(2-3):235-48. PubMed ID: 15560968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenomenologically distinct psychotomimetic effects of ketamine are associated with cerebral blood flow changes in functionally relevant cerebral foci: a continuous arterial spin labelling study.
    Pollak TA; De Simoni S; Barimani B; Zelaya FO; Stone JM; Mehta MA
    Psychopharmacology (Berl); 2015 Dec; 232(24):4515-24. PubMed ID: 26438425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.